ÂÜÀòÂÒÂ×

Michelle Doyle is a Senior Research Technician currently involved with the UK Dementia Research Institute and has been with Cardiff University since March 2010, contributing to various projects including the MicroEnvironment Trial for AML Patients and CAR T Therapy Trials for Blood Cancer. With a focus on patient-centered research, Michelle is skilled in qPCR analysis related to AML leukaemia and provides technical support for clinical trials across the UK, Denmark, and New Zealand. Previous roles include a temporary contract at Cytiva involving mammalian cell culture and product development, as well as a 19-year tenure as a Development Specialist at GE Healthcare, where Michelle engaged in a wide array of research and development projects related to cellular assays and cancer modeling. Michelle holds a Bachelor of Science in Applied Biosciences, a Higher National Certificate in Applied Biology, and a Higher National Diploma in Science Technology of Food from the University of Wales.